Transgenomic, Inc. (OTC BB: TBIO)

Transgenomic, Inc. (OTC BB: TBIO), a global biotechnology company, is focused on providing novel products and services for automated high sensitivity genetic variation and mutation analysis. The company’s offerings currently include systems, products, discovery and laboratory testing services that find application in the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. For further information, visit the Company’s web site at www.transgenomic.com.